Contact the MD NAD editorial team
We publish research summaries on NAD+, NMN, NR, and IV infusion protocols. We are an editorial project — not a clinic, not a medical service.
Get in touch
MD NAD is an independent editorial publisher that summarizes peer-reviewed research on NAD+ — coenzyme biology, precursor pharmacology, IV infusion protocols, and the clinical trial record. We are not a clinic, not a vendor, and we do not provide medical advice or consultation.
For editorial inquiries, citation corrections, or research questions: use the form below. We review all messages but cannot respond to requests for medical advice, dosing guidance, or treatment recommendations — those questions are appropriate for a licensed healthcare provider.
NOTE
What we can help with: citation corrections or broken reference links, editorial questions about the research summaries, general questions about the NAD+ literature that are publicly documented.
What we cannot help with: medical advice, dosing recommendations, or treatment plans; sourcing, purchasing, or compounding NAD+ or its precursors; referrals to clinicians or IV therapy providers.
Our response time is typically 3–5 business days.